The Magazine for Sleep Professionals
Thursday, August 20, 2026
Pfizer Inc. announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age or older. The FDA decision is primarily […]
With independent studies showing that 8 out of 10 people use their inhalers incorrectly1, inhaler technique training supports more accurate drug delivery, helping patients get the full benefit of their medication, and resulting in better disease management. The Vitalograph AIM™ (Aerosol Inhalation Monitor) is designed to assist medical practitioners in […]
A new study funded by the American Lung Association reveals that young adults who used e-cigarettes were more likely to develop respiratory issues within one year of vaping. The study, titled, “Association of Electronic Cigarette Use with Respiratory Symptom Development among US Young Adults,” will be published in the American Journal of Respiratory and Critical Care Medicine, one […]
In its latest clinical practice guideline on evaluation and treatment of asthma, an American Thoracic Society expert guidelines panel has addressed the use of fractional exhaled nitric oxide (FeNO) to guide the treatment of asthma. The guideline was published online in the Nov. 15 issue of the American Journal of Respiratory and Critical […]
Congressman Jamie Raskin (MD) introduced a bipartisan resolution recognizing the significant contributions that respiratory therapists have made during the COVID-19 pandemic. The introduction of the bipartisan resolution falls during National Respiratory Care Week and demonstrates Congress’s continued support for the exceptional respiratory therapists who live and work in our communities. […]
“The ATS reiterates our long-held position – e-cigarettes are not “safe” and the claims that e-cigarettes are a harm reduction tool remain unproven. All e-cigarettes have significant health risks including nicotine addiction and respiratory disease,” said ATS President Lynn Schnapp, MD, ATSF. The ATS notes that the FDA has finally issued decisions […]
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the launch of Inhaler Tales – a national campaign aimed at raising awareness about the role inhaler misuse may play in inadequate disease control.1 Central to the campaign is an animated inhaler voiced by actress, producer, and entrepreneur Sarah […]
The Food and Drug Administration issued decisions on new tobacco product applications, addressing the over 6 million unique products and flavor variations submitted for agency review. Missing from the FDA’s announcement was a decision on a company that has the largest e-cigarette market share – Juul. “How the FDA could […]
Philip Morris International Inc. announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction. If approved, the treatment can address the significant unmet medical need of the over 83 million people, in the U.S. alone, at intermediate […]
Women who were highly exposed to ultrafine particles in air pollution during their pregnancy were more likely to have children who developed asthma, according to a study published in the American Journal of Respiratory and Critical Care Medicine. This is the first time asthma has been linked with prenatal exposure […]
